On 8 December 2022, Sartorius AG announced that it had subscribed to a directed share issue in BICO equal to 10 per cent of the outstanding shares in BICO prior to the transaction. Added to Sartorius’ already existing shareholding in BICO, Sartorius’ total shareholding in BICO amounts to approximately 10.1 per cent of the shares and 8.5 per cent of the votes in the company.

Sartorius is an international partner of life science research and the biopharmaceutical industry. BICO is a provider of life science solutions and laboratory automation. Sartorius is listed on the Frankfurt Stock Exchange and BICO is listed on Nasdaq Stockholm.

Gernandt & Danielsson advised Sartorius together with Milbank with a team consisting of partner Carl Westerberg and senior associate Daniel Sveen.